Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SERENE-UC
NCT02065622Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2014
- Primary completion
- Sep 2019
- Modality
- Monoclonal Antibodies
- Countries
- 20
01
Overview
A Phase 3 trial of adalimumab in ulcerative colitis (UC), sponsored by AbbVie Inc.. Started Mar 2014; status: completed.
02
Drugs
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02065622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065622.